GB1037735A - Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamine - Google Patents
Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamineInfo
- Publication number
- GB1037735A GB1037735A GB2290/65A GB229065A GB1037735A GB 1037735 A GB1037735 A GB 1037735A GB 2290/65 A GB2290/65 A GB 2290/65A GB 229065 A GB229065 A GB 229065A GB 1037735 A GB1037735 A GB 1037735A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acetyl
- phenol
- amino
- toloxamine
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An analgesic composition consists of N-acetyl-p-amino phenol and phenyltoloxamine, optionally with a pharmaceutically-acceptable carrier. The phenyltoloxamine may be present as a pharmaceutically acceptable acid addition salt thereof e.g. the citrate. Conventional lubricating and disintegrating agents may be added to the solid dosage forms and conventional bodying agents, acid components for pH adjustment and solubilization, and flavourings may be added to the liquid dosage forms.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2290/65A GB1037735A (en) | 1965-01-19 | 1965-01-19 | Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamine |
| FR3404A FR4821M (en) | 1965-01-19 | 1965-01-27 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2290/65A GB1037735A (en) | 1965-01-19 | 1965-01-19 | Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1037735A true GB1037735A (en) | 1966-08-03 |
Family
ID=9736961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2290/65A Expired GB1037735A (en) | 1965-01-19 | 1965-01-19 | Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamine |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR4821M (en) |
| GB (1) | GB1037735A (en) |
-
1965
- 1965-01-19 GB GB2290/65A patent/GB1037735A/en not_active Expired
- 1965-01-27 FR FR3404A patent/FR4821M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR4821M (en) | 1967-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES460743A1 (en) | Preserving liquid antacid medicinal formulations | |
| ES410825A1 (en) | Quinoline derivatives | |
| JPS52108028A (en) | Remedies for dysacousis | |
| GB1037735A (en) | Analgesic compositions comprising n-acetyl-p-amino-phenol and phenyl-toloxamine | |
| ES409333A1 (en) | Stabilization of aqueous solutions of bromine | |
| AR215125A1 (en) | COMPOSITION TO BE INGESTED BY ANIMALS, CONTAINING AN AGENT TO IMPROVE THE USE OF NUTRITIVE SUBSTANCES AND GROWTH FOR RUMIANTS AND SPECIES OF ANIMALS WITH SIMILAR DIGESTIVE PHYSIOLOGY AND PROCEDURE AND CONCENTRATE TO PREPARE IT | |
| GB997975A (en) | Pharmaceutical compositions containing a cresol or a mixture of cresols | |
| ES368955A1 (en) | Procedure for preparing substitute guanidines. (Machine-translation by Google Translate, not legally binding) | |
| GB1090481A (en) | Improvements in and relating to diuretic compositions | |
| GB1056212A (en) | Improved antacid composition and method for preparing the same | |
| ES451879A1 (en) | Composition for bucco-dental usage | |
| ES386287A1 (en) | 7-alkoxy-2{60 -carboxy-1{60 ,2{62 di-alkyl-1,2,3,4,9,12{60 hexahydrophen anthrenes and esters and salts thereof | |
| GB1036059A (en) | Improvements in or relating to the inhibition of bacterial growth | |
| SE326717B (en) | ||
| GB1478286A (en) | 4-fluoro-6-nitro phenol derivatives methods for their preparation and their use | |
| GB1078745A (en) | Composition and process for inhibiting egg-production in birds | |
| GB1091299A (en) | ªÐ-acetamido-benzyl alcohol | |
| GB1029050A (en) | Improvements in and relating to new flavone and the process of preparation and application thereof | |
| GB1047919A (en) | Morpholine derivative, preparation thereof and compositions containing same | |
| ES346611A1 (en) | A procedure for preparing a pharmaceutical composition intended for the treatment of broncoconstriction and hypertension. (Machine-translation by Google Translate, not legally binding) | |
| GB991376A (en) | Pharmaceutical compositions containing 3-ethylsalicylic acid | |
| GB1121064A (en) | Antibiotic compositions and the manufacture thereof | |
| JPS5234914A (en) | Method and composition for preventing failing of milk secretion of live stocks | |
| BE759304Q (en) | Phenoxyalkylamines coronary vasodilators and | |
| ZA711290B (en) | Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations |